Aeroallergen sensitization in chronic spontaneous urticaria
Allergologia et Immunopathologia · 01.05.2026 · 54 (3) · 96-101
DOI: 10.15586/aei.v54i3.1631 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergologia et Immunopathologia, online erschienen am 01.05.2026. Verfasst von Selma Yeşilkaya. Beteiligte Einrichtung: Division of Immunology and Allergy, Samsun Training and Research Hospital, Samsun, Turkey; selmayesilkaya@hotmail.com. Hauptthemen laut MEDLINE: Allergens, Chronic Urticaria, Rhinitis, Allergic. Gefördert von: None..
Abstract (Originalsprache)
Aim
To investigate the prevalence and distribution of aeroallergen sensitization in adult patients with chronic spontaneous urticaria (CSU), compared to a control group with allergic rhinitis (AR).
Method
This retrospective cross-sectional study included 158 CSU and 166 AR patients examined between October 15, 2023, and July 1, 2025. Demographics, clinical features, skin prick test (SPT) results for common aeroallergens (house dust mites, pollens, molds, animal danders), and hematological markers (e.g., basophil/eosinophil counts, total IgE) were examined.
Results
The CSU group was significantly older than controls (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Immunology and Allergy, Samsun Training and Research Hospital, Samsun, Turkey; selmayesilkaya@hotmail.com.
Förderung
- None.
Zitieren
APA
Yeşilkaya, S. (2026). Aeroallergen sensitization in chronic spontaneous urticaria. Allergologia et Immunopathologia, 54(3), 96-101. https://doi.org/10.15586/aei.v54i3.1631
Vancouver
Yeşilkaya S. Aeroallergen sensitization in chronic spontaneous urticaria. Allergologia et Immunopathologia. 2026;54(3):96-101. doi:10.15586/aei.v54i3.1631
BibTeX
@article{Yeilkaya2026,
author = {Yeşilkaya, Selma},
title = {Aeroallergen sensitization in chronic spontaneous urticaria},
journal = {Allergologia et Immunopathologia},
year = {2026},
volume = {54},
number = {3},
pages = {96--101},
doi = {10.15586/aei.v54i3.1631}
}
EUVIMED